Pla2g7 regulates bone homeostasis via Alox12/12-HETE/Gpr31 signaling axis

作者：Jiayan Jin, Zeyu Zheng, Jianhua Gu, Qibin Zhang, Zhikun Xu, Zhenhua Feng, Siyue Tao, Simin He, Cheng Jiao, Jian Wang, Hou‐Feng Zheng, Shishi Li, Fengdong Zhao, Jian Chen · 发表于：Nature Communications · 年份：2025 · DOI：10.1038/s41467-025-66285-8 · 被引用次数：7 · 研究领域：Bone Metabolism and Diseases、MicroRNA in disease regulation、Ferroptosis and cancer prognosis

Bone homeostasis mainly depends on the equilibrium of osteoclasts and osteoblasts, overactivated osteoclasts play a pivotal role in the progression of osteoporosis. Here, we revealed that Pla2g7 (phospholipase A2 group VII) was positively correlated with bone resorption in clinic. By single-cell RNA-seq data analysis, Pla2g7 was found highly enriched in osteoclasts along the developmental trajectory, which promoted osteoclast differentiation. Inhibition of Pla2g7 by Darapladib impaired both human and mice osteoclast differentiation, meanwhile, Pla2g7-deficient mice showed higher bone mass and restored the ovariectomy-induced bone loss. Mechanistically, we identified that Alox12 (arachidonate 12-lipoxygenase) mediated-arachidonic acid metabolism is a key determinant in Pla2g7 enhanced osteoclast differentiation. Its metabolite 12-HETE (12-hydroxyeicosatetraenoic acid) activated Gpr31 to regulate osteoclast formation via p38 MAPK pathway and mitochondrial energy metabolism. Collectively, our study uncovers an Alox12/12-HETE/Gpr31 axis that regulates Pla2g7-induced osteoclast differentiation, and provides a new insight for osteoporosis treatment. Pla2g7 is a secreted enzyme mainly produced by myeloid cells and exerts a significant role in a spectrum of metabolic and inflammatory disorders. Here they show that Pla2g7 expression is enriched in osteoclasts and is associated with bone resorption, revealing an important role in bone homeostasis.